Literature DB >> 26012491

Voxel-based morphometry of the marmoset brain: In vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson's disease model.

K Hikishima1, K Ando2, Y Komaki1, K Kawai2, R Yano3, T Inoue2, T Itoh2, M Yamada4, S Momoshima5, H J Okano6, H Okano7.   

Abstract

Movement dysfunction in Parkinson's disease (PD) is caused by the degeneration of dopaminergic (DA) neurons in the substantia nigra (SN). Here, we established a method for voxel-based morphometry (VBM) and automatic tissue segmentation of the marmoset monkey brain using a 7-T animal scanner and applied the method to assess DA degeneration in a PD model, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated animals, with tyrosine-hydroxylase staining. The most significant decreases of local tissue volume were detected in the bilateral SN of MPTP-treated marmoset brains (-53.0% in right and -46.5% in left) and corresponded with the location of DA neurodegeneration found in histology (-65.4% in right). In addition to the SN, the decreases were also confirmed in the locus coeruleus, and lateral hypothalamus. VBM using 7-T MRI was effective in detecting volume loss in the SN of the PD-model marmoset. This study provides a potential basis for the application of VBM with ultra-high field MRI in the clinical diagnosis of PD. The developed method may also offer value in automatic whole-brain evaluation of structural changes for the marmoset monkey.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Callithrix jacchus; MPTP; Parkinson’s disease; VBM; common marmoset; substantia nigra

Mesh:

Substances:

Year:  2015        PMID: 26012491     DOI: 10.1016/j.neuroscience.2015.05.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

Review 1.  The use of nonhuman primate models to understand processes in Parkinson's disease.

Authors:  Javier Blesa; Inés Trigo-Damas; Natalia López-González Del Rey; José A Obeso
Journal:  J Neural Transm (Vienna)       Date:  2017-03-29       Impact factor: 3.575

2.  KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson's Disease.

Authors:  Qiao Mao; Xiaoping Wang; Bin Chen; Longhua Fan; Shuhong Wang; Yong Zhang; Xiandong Lin; Yuping Cao; Yun-Cheng Wu; Jiawu Ji; Jianying Xu; Jianming Zheng; Huihao Zhang; Chengchou Zheng; Wenzhong Chen; Wenhong Cheng; Xingqun Luo; Kesheng Wang; Lingjun Zuo; Longli Kang; Chiang-Shan R Li; Xingguang Luo
Journal:  Front Neurosci       Date:  2020-06-23       Impact factor: 4.677

Review 3.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

4.  Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

Authors:  Naying He; Huawei Ling; Bei Ding; Juan Huang; Yong Zhang; Zhongping Zhang; Chunlei Liu; Kemin Chen; Fuhua Yan
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

5.  Brain structural changes in cynomolgus monkeys administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A longitudinal voxel-based morphometry and diffusion tensor imaging study.

Authors:  Hyeonseok S Jeong; Sang-Rae Lee; Jieun E Kim; In Kyoon Lyoo; Sujung Yoon; Eun Namgung; Kyu-Tae Chang; Bom Sahn Kim; Sejung Yang; Jooyeon J Im; Saerom Jeon; Ilhyang Kang; Jiyoung Ma; Yong-An Chung; Soo Mee Lim
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

6.  Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.

Authors:  Michel Modo; William R Crum; Madeline Gerwig; Anthony C Vernon; Priya Patel; Michael J Jackson; Sarah Rose; Peter Jenner; Mahmoud M Iravani
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

7.  In vivo microscopic voxel-based morphometry with a brain template to characterize strain-specific structures in the mouse brain.

Authors:  Keigo Hikishima; Yuji Komaki; Fumiko Seki; Yasuyuki Ohnishi; Hirotaka J Okano; Hideyuki Okano
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

8.  Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.

Authors:  Tuva R Hope; Per Selnes; Irena Rektorová; Lubomira Anderkova; Nela Nemcova-Elfmarkova; Zuzana Balážová; Anders Dale; Atle Bjørnerud; Tormod Fladby
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

9.  Normal tension glaucoma-like degeneration of the visual system in aged marmosets.

Authors:  Takahiko Noro; Kazuhiko Namekata; Atsuko Kimura; Yuriko Azuchi; Nanako Hashimoto; Keiko Moriya-Ito; Yuji Komaki; Chia-Ying Lee; Norio Okahara; Xiaoli Guo; Chikako Harada; Euido Kim; Tadashi Nakano; Hiroshi Tsuneoka; Takashi Inoue; Erika Sasaki; Hironobu Tokuno; Takayuki Harada
Journal:  Sci Rep       Date:  2019-10-16       Impact factor: 4.379

10.  Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations.

Authors:  Kiyoshi Ando; Takashi Inoue; Keigo Hikishima; Yuji Komaki; Kenji Kawai; Ryo Inoue; Chiyoko Nishime; Eiko Nishinaka; Koji Urano; Hideyuki Okano
Journal:  Behav Pharmacol       Date:  2020-02       Impact factor: 2.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.